Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
Richard H
RH
Roe
Emmett T
ET
Cunningham
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D028227:Amyloid Neuropathies, Familial / Q000188:drug therapy / Q000235:genetics*; D004351:Drug Resistance; D005128:Eye Diseases / Q000188:drug therapy / Q000235:genetics*; D014644:Genetic Variation; D005998:Glycine; D006639:Histidine; D006801:Humans; D007249:Inflammation / Q000235:genetics; D017354:Point Mutation; D011228:Prealbumin / Q000235:genetics*; D014443:Tyrosine; D014633:Valine; D014822:Vitreous Body
D000305:Adrenal Cortex Hormones; D011228:Prealbumin; D014443:Tyrosine; D006639:Histidine; D014633:Valine; D005998:Glycine